| abstract |
The present disclosure relates to a pyrazolo[1,5-a]pyridine derivative, and a preparation method and medical use thereof. Specifically, the present disclosure relates to a pyrazolo[1,5-a]pyridine derivative shown in general formula (I), a preparation method of the derivative, a pharmaceutically acceptable salt of the derivative, and use of the derivative or salt as a therapeutic agent, especially as a rearranged during transfection (RET) inhibitor. Definitions of substituents in the general formula (I) are the same as definitions in the specification. |